Beijing Leadman Biochemistry Co Ltd (300289) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.007x

Based on the latest financial reports, Beijing Leadman Biochemistry Co Ltd (300289) has a cash flow conversion efficiency ratio of 0.007x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥11.89 Million ≈ $1.74 Million USD) by net assets (CN¥1.71 Billion ≈ $250.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 300289 company net worth for the company's overall valuation and market capitalisation.

Beijing Leadman Biochemistry Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Beijing Leadman Biochemistry Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Beijing Leadman Biochemistry Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Beijing Leadman Biochemistry Co Ltd ranked by their cash flow conversion efficiency. Explore how high is Beijing Leadman Biochemistry Co Ltd's earnings quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Hearts and Minds Investments Ltd
AU:HM1
-0.005x
Soft-World International
TWO:5478
0.116x
Chung Hwa Pulp Corp
TW:1905
-0.002x
Hangzhou Electn Soul Network
SHG:603258
0.008x
DINGDONG CAYMAN 2ADR/3 A
F:945
0.279x
Dongguan Chitwing Technology Co Ltd
SHE:002855
0.242x
Pareto Bank ASA
OL:PARB
-0.015x
Automotive Properties Real Estate Investment Trust
TO:APR-UN
0.016x

Annual Cash Flow Conversion Efficiency for Beijing Leadman Biochemistry Co Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Beijing Leadman Biochemistry Co Ltd from 2008 to 2025. View 300289 live share price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥1.67 Billion
≈ $244.48 Million
CN¥29.16 Million
≈ $4.27 Million
0.017x -51.93%
2024-12-31 CN¥1.72 Billion
≈ $251.48 Million
CN¥62.41 Million
≈ $9.13 Million
0.036x -51.25%
2023-12-31 CN¥1.80 Billion
≈ $264.07 Million
CN¥134.42 Million
≈ $19.67 Million
0.074x +21.74%
2022-12-31 CN¥1.78 Billion
≈ $260.54 Million
CN¥108.93 Million
≈ $15.94 Million
0.061x +1.65%
2021-12-31 CN¥1.98 Billion
≈ $289.46 Million
CN¥119.06 Million
≈ $17.42 Million
0.060x -38.79%
2020-12-31 CN¥1.38 Billion
≈ $201.75 Million
CN¥135.56 Million
≈ $19.84 Million
0.098x +14.38%
2019-12-31 CN¥1.45 Billion
≈ $212.18 Million
CN¥124.65 Million
≈ $18.24 Million
0.086x +52.52%
2018-12-31 CN¥1.44 Billion
≈ $210.34 Million
CN¥81.02 Million
≈ $11.86 Million
0.056x -33.59%
2017-12-31 CN¥1.43 Billion
≈ $208.55 Million
CN¥120.97 Million
≈ $17.70 Million
0.085x +38.74%
2016-12-31 CN¥1.34 Billion
≈ $195.60 Million
CN¥81.78 Million
≈ $11.97 Million
0.061x -56.65%
2015-12-31 CN¥1.26 Billion
≈ $184.37 Million
CN¥177.82 Million
≈ $26.02 Million
0.141x +1267.55%
2014-12-31 CN¥1.09 Billion
≈ $159.89 Million
CN¥-13.21 Million
≈ $-1.93 Million
-0.012x -111.38%
2013-12-31 CN¥851.12 Million
≈ $124.55 Million
CN¥90.45 Million
≈ $13.24 Million
0.106x +39.78%
2012-12-31 CN¥761.02 Million
≈ $111.36 Million
CN¥57.86 Million
≈ $8.47 Million
0.076x -42.81%
2011-12-31 CN¥220.77 Million
≈ $32.31 Million
CN¥29.34 Million
≈ $4.29 Million
0.133x -60.29%
2010-12-31 CN¥159.72 Million
≈ $23.37 Million
CN¥53.46 Million
≈ $7.82 Million
0.335x +12.77%
2009-12-31 CN¥105.32 Million
≈ $15.41 Million
CN¥31.26 Million
≈ $4.57 Million
0.297x +13.30%
2008-12-31 CN¥83.90 Million
≈ $12.28 Million
CN¥21.98 Million
≈ $3.22 Million
0.262x --

About Beijing Leadman Biochemistry Co Ltd

SHE:300289 China Medical Devices
Market Cap
$460.12 Million
CN¥3.14 Billion CNY
Market Cap Rank
#12794 Global
#3777 in China
Share Price
CN¥5.78
Change (1 day)
+0.87%
52-Week Range
CN¥5.28 - CN¥9.25
All Time High
CN¥23.05
About

Beijing Leadman Biochemistry Co.,Ltd. researches and develops, manufactures, and sells vitro diagnostic reagents and instruments, and biochemical raw materials in the People's Republic of China. The company offers biochemical raw materials, including enzymes, antigens, coenzymes, antibodies, buffers, enzyme substrates, culture mediums, stain agents, amino acids, and other products for biotechnolo… Read more